McMurry-Heath Michelle — SEC Form 4 filings
SEC reporting owner CIK 1904156. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-04.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-05-02 to 2026-06-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 32,871 shares, $585,744 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 1,970 shares @ $119.49 ($235,395) in REVVITY, INC., filed 2025-02-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REVVITY, INC. (RVTY) | Director | 6 | — | 3 legs · 3,170 sh · $349,050 | 6 |
| Bioventus Inc. (BVS) | Director | 7 | — | 2 legs · 29,701 sh · $236,694 | 11 |
Form 4 filings — McMurry-Heath Michelle
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-04 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 32,282 @ $0 · Option exercise (M): 32,282 (derivative) @ $0 · Grant/award (A): 25,146 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | REVVITY, INC. (RVTY) | Grant/award (A): 1,015 @ $0 · Grant/award (A): 1,265 @ $0 | EDGAR |
| 2026-03-13 | 4 | Bioventus Inc. (BVS) | Sale (S): 12,000 @ $8.79 | EDGAR |
| 2026-02-25 | 4 | REVVITY, INC. (RVTY) | Sale (S): 600 @ $97.26 | EDGAR |
| 2025-11-10 | 4 | Bioventus Inc. (BVS) | Sale (S): 17,701 @ $7.42 | EDGAR |
| 2025-06-04 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 26,493 @ $0 · Option exercise (M): 26,493 (derivative) @ $0 · Grant/award (A): 32,282 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | REVVITY, INC. (RVTY) | Sale (S): 600 @ $92.17 | EDGAR |
| 2025-05-01 | 4 | REVVITY, INC. (RVTY) | Grant/award (A): 1,074 @ $0 · Grant/award (A): 1,338 @ $0 | EDGAR |
| 2025-02-07 | 4 | REVVITY, INC. (RVTY) | Sale (S): 1,970 @ $119.49 | EDGAR |
| 2024-06-18 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 386 @ $0 · Option exercise (M): 386 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Bioventus Inc. (BVS) | Grant/award (A): 26,493 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 30,400 @ $0 · Option exercise (M): 30,400 (derivative) @ $0 | EDGAR |
| 2024-05-02 | 4 | REVVITY, INC. (RVTY) | Grant/award (A): 977 @ $0 · Grant/award (A): 1,218 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1904156 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →